PTEN mutation spectrum in breast cancers and breast hyperplasia

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 9, 2010, Pages 1303-1311

  Yang, Julun ^a   Ren, Yan ^a   Wang, Li ^a   Li, Baolin ^b   Chen, Yue ^a   Zhao, Wenxing ^a   Xu, Wenmang ^a   Li, Tao ^a   Dai, Fang ^a  

^a KUNMING GENERAL HOSPITAL   (China)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Breast cancer; Mammary hyperplasia; Mutation; PTEN; Tumor suppressor gene

Indexed keywords

DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; BREAST HYPERPLASIA; CHINA; CHROMOSOME 10; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADULT; AGED; BIOSYNTHESIS; BREAST TUMOR; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PTEN PHOSPHOHYDROLASE; SEQUENCE ANALYSIS, DNA;

EID: 77955483827     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0781-3     Document Type: Article

References (25)

1. IU Ali LM Schriml M Dean 1999 Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity J Natl Cancer Inst 91 22 1922 1932 10.1093/jnci/91.22.1922 1:CAS:528:DyaK1MXotVaitr4%3D 10564676
2. A Alimov C Li R Gizatullin V Fredriksson B Sundelin G Klein E Zabarovsky U Bergerheim 1999 Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma Anticancer Res 19 5B 3841 3846 1:CAS:528:DC%2BD3cXkt1Gq 10628321
3. D Bonneau M Longy 2000 Mutations of the human PTEN gene Hum Mutat 16 2 109 122 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0 1:CAS:528:DC%2BD3cXlvFKgt7g%3D 10923032
4. S Bose A Crane H Hibshoosh M Mansukhani L Sandweis R Parsons 2002 Reduced expression of PTEN correlates with breast cancer progression Hum Pathol 33 4 405 409 10.1053/hupa.2002.124721 1:CAS:528:DC%2BD38XltlOksro%3D 12055674
5. T Bouras MC Southey DJ Venter 2001 Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu Cancer Res 61 3 903 907 1:CAS:528:DC%2BD3MXhsFSrtbY%3D 11221879
6. EM Bruckheimer BT Gjertsen TJ McDonnell 1999 Implications of cell death regulation in the pathogenesis and treatment of prostate cancer Semin Oncol 26 4 382 398 1:CAS:528:DyaK1MXmt1Sju7k%3D 10482181
7. E Bussaglia RM Pujol MJ Gil RM Marti A Tuneu MI Febrer V Garcia-Patos EM Ruiz M Barnadas M Alegre, et al. 2002 PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome J Investig Dermatol 118 4 639 644 10.1046/j.1523-1747.2002.01728.x 1:CAS:528:DC%2BD38Xjt1Cisr8%3D 11918710
8. MJ Chung SH Jung BJ Lee MJ Kang DG Lee 2004 Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer Pathol Int 54 1 10 15 10.1111/j.1440-1827.2004. 01576.x 1:CAS:528:DC%2BD2MXivFWgtLk%3D 14674989
9. MP Davies FE Gibbs N Halliwell KA Joyce MM Roebuck ML Rossi J Salisbury DR Sibson L Tacconi C Walker 1999 Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas Br J Cancer 79 9-10 1542 1548 10.1038/sj.bjc.6690246 1:CAS:528:DyaK1MXitFGrsrg%3D 10188904
10. PL Depowski SI Rosenthal JS Ross 2001 Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer Mod Pathol 14 7 672 676 10.1038/modpathol.3880371 1:STN:280:DC%2BD3Mvgtlyqsw%3D%3D 11454999
11. JM Garcia J Silva C Pena V Garcia R Rodriguez MA Cruz B Cantos M Provencio P Espana F Bonilla 2004 Promoter methylation of the PTEN gene is a common molecular change in breast cancer Genes Chromosom Cancer 41 2 117 124 10.1002/gcc.20062 1:CAS:528:DC%2BD2cXnslWlu74%3D 15287024
12. F Guenard Y Labrie G Ouellette CJ Beauparlant P Bessette J Chiquette R Laframboise J Lepine B Lesperance R Pichette, et al. 2007 Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families Fam Cancer 6 4 483 490 10.1007/s10689-007-9151-y 1:CAS:528:DC%2BD2sXhtF2htb3J 17636424
13. JO Lee H Yang MM Georgescu A Di Cristofano T Maehama Y Shi JE Dixon P Pandolfi NP Pavletich 1999 Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association Cell 99 3 323 334 10.1016/S0092-8674(00)81663-3 1:CAS:528: DyaK1MXnt1Gqs7g%3D 10555148
14. J Li C Yen D Liaw K Podsypanina S Bose SI Wang J Puc C Miliaresis L Rodgers R McCombie, et al. 1997 PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 5308 1943 1947 10.1126/science.275.5308.1943 1:CAS:528:DyaK2sXit1Wgtbk%3D 9072974
15. Y Lu Q Yu JH Liu J Zhang H Wang D Koul JS McMurray X Fang WK Yung KA Siminovitch, et al. 2003 Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades J Biol Chem 278 41 40057 40066 10.1074/jbc.M303621200 1:CAS:528:DC%2BD3sXnvFamsLs%3D 12869565
16. DJ Marsh V Coulon KL Lunetta P Rocca-Serra PL Dahia Z Zheng D Liaw S Caron B Duboue AY Lin AL Richardson, et al. 1998 Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation Hum Mol Genet 7 3 507 515 10.1093/hmg/7.3.507 1:CAS:528:DyaK1cXitFWku74%3D 9467011
17. A Perren LP Weng AH Boag U Ziebold K Thakore PL Dahia P Komminoth JA Lees LM Mulligan GL Mutter, et al. 1999 Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast Am J Pathol 155 4 1253 1260 1:CAS:528:DyaK1MXntFWmt7g%3D 10514407
18. E Rhei L Kang F Bogomolniy MG Federici PI Borgen J Boyd 1997 Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas Cancer Res 57 17 3657 3659 1:CAS:528:DyaK2sXlvFentr4%3D 9288766
19. PA Steck MA Pershouse SA Jasser WK Yung H Lin AH Ligon LA Langford ML Baumgard T Hattier T Davis, et al. 1997 Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 4 356 362 10.1038/ng0497-356 1:CAS:528: DyaK2sXitF2hs70%3D 9090379
20. G Tate T Suzuki T Mitsuya 2007 Mutation of the PTEN gene in a human hepatic angiosarcoma Cancer Genet Cytogenet 178 2 160 162 10.1016/j. cancergencyto.2007.07.017 1:CAS:528:DC%2BD2sXhtF2lsr3I 17954274
21. L Wang A Hoque RZ Luo J Yuan Z Lu A Nishimoto J Liu AA Sahin SM Lippman RC Bast Jr, et al. 2003 Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer Clin Cancer Res 9 10 Pt 1 3660 3666 1:CAS:528:DC%2BD3sXosVOlu7k%3D 14506155
22. L Wang WL Wang Y Zhang SP Guo J Zhang QL Li 2007 Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma Hepatol Res 37 5 389 396 10.1111/j.1872-034X.2007.00042.x 1:CAS:528:DC%2BD2sXmtlSmsbs%3D 17441812
23. Y Yaginuma T Yamashita T Ishiya A Morizaki Y Katoh T Takahashi H Hayashi M Ishikawa 2000 Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers Mol Carcinog 27 2 110 116 10.1002/(SICI)1098-2744(200002)27: 2<110::AID-MC6>3.0.CO;2-E 1:CAS:528:DC%2BD3cXhtF2mtbY%3D 10657903
24. M Yoshimoto IW Cunha RA Coudry FP Fonseca CH Torres FA Soares JA Squire 2007 FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome Br J Cancer 97 5 678 685 10.1038/sj.bjc.6603924 1:CAS:528:DC%2BD2sXpsF2ksLc%3D 17700571
25. L Zhu WT Loo WC Louis 2007 PTEN and VEGF: possible predictors for sentinel lymph node micro-metastasis in breast cancer Biomed Pharmacother 61 9 558 561 10.1016/j.biopha.2007.08.015 1:CAS:528:DC%2BD2sXhtF2ru73L 17919877